Method Profile

Dual-Chamber Tumor–Cardiac Microtissues with Automated Morphometry

Compare morphology in separate breast-cancer and cardiac cell-line collagen tissues maintained together, with a separate U87 application.

Multiple OrgansOrgan Chips
A false-colored breast tumor spheroid with green outer cells and purple inner layers.
False-colored scanning electron micrograph of a breast tumor spheroid. (Khuloud T. Al-Jamal, David McCarthy & Izzat Suffian, CC BY 4.0)

Research Applications

Explore whether culture setting changes a chemotherapy-associated morphological response across tumor and cardiac compartments.

Model & Design

SKBR3 breast-cancer and AC16 cardiac cell-line tissues in separate chambers; U87 glioblastoma tissue tested separately. Transwell monocultures and cocultures are comparators.

Experimental Format

Collagen at 2 mg/mL and 200,000 cells/mL; imaging on days 3 and 7. Doxorubicin 10 μM for 48 hours; the separate U87 model also receives temozolomide 200 μM for 48 hours after three days of culture.

Model Components

  • Component

    Morphology and identity

    Description

    HER2, α-actinin or nestin fluorescence with actin and nuclear staining; three biological specimens and five z-stacks per specimen.

  • Component

    Image analysis

    Description

    AIAPS combines thresholding, erosion and watershed segmentation of two-dimensional z-stack projections to estimate cell contours and diameters. Fluorescent-bead measurements are compared with FIJI.

Measurements & Endpoints

  • Projected cell diameter
  • Cell clustering and network organization
  • Lineage-associated marker retention

Analysis

Interpret significant size shifts as morphological responses. Keep the paired breast–cardiac study separate from U87 and do not equate projected size with direct survival or functional cardiotoxicity.

Published Evidence

  • Study Sample

    Three biological specimens per tissue condition, with five z-stacks per specimen. The bead comparison uses three image replicates with five images each.

    Comparison

    Device versus Transwell; monoculture versus coculture; untreated versus drug-treated tissue; AIAPS versus FIJI for bead sizing.

    Finding

    AC16 cell size decreased significantly after doxorubicin in the device but not Transwell. SKBR3 size changed across the tested culture conditions. Figure 6 reports U87 size reduction with both drugs in the device. Day-7 breast-cell sizes and same-time U87 device/Transwell comparisons were not significantly different.

    Interpretation & Limits
    • Established cell lines and restricted doses; no patient-response validation.
    • AIAPS and FIJI bead estimates differed significantly despite both falling within the nominal 1–10 μm range.
    • Two-dimensional projected contours incompletely capture three-dimensional morphology.
    • No direct cardiac functional or clinical cardiotoxicity endpoint.
    Study Design

    Primary study comparisons of the named models, exposures and measured outcomes.

Sources

  1. 3D Multi-Tissue microphysiological system for Anti-Cancer and cardiotoxicity drug screening with automated image analysis. Discover Applied Sciences (2025). ↗